摘要
丙型病毒性肝炎是肝硬化、肝细胞癌的重要病因之一。我国约有1000万例慢性HCV感染者,但是,我国仍有大约70%以上的HCV感染者并没有被发现。根据世界卫生组织提出到2030年消除病毒性肝炎作为公共卫生危害的目标,以及医疗机构是目前我国发现HCV感染者和患者的主要场所,我们制定了《中国丙型病毒性肝炎院内筛查管理流程》,希望促进医疗机构管理、临床、检验、感染控制的多学科、多部门联合,加强医疗机构对检出抗-HCV阳性就诊者的咨询和转诊,促进慢性丙型肝炎患者的诊断和抗病毒治疗。
Viral hepatitis C is one of the important causes of liver cirrhosis and hepatocellular carcinoma.There are approximately 10 million cases of chronic hepatitis C virus(HCV)infection in China.However,over 70%of HCV infections of China have not yet been detected.According to the goal of“eliminating viral hepatitis as a public health threat by 2030"of the World Health Organization Viral Hepatitis Stratrgy,and the fact that medical institutions remain the main places for detecting HCV infections or patients in China at present,we established the"In-hospital process for viral hepatitis C screening and management in China(Draft)”,with intention to promote multidisciplinary collaboration and cooperation among the departments of clinic,laboratory,infection control,management,and etc.in medical institutions,and strengthen consultation and referral of patients with detected HCV antibodies and advance the diagnosis and antiviral treatment of patients with chronic hepatitis C.
出处
《临床肝胆病杂志》
CAS
北大核心
2021年第7期1534-1539,共6页
Journal of Clinical Hepatology
关键词
丙型肝炎
流程
筛查
诊断
治疗
Hepatitis C
Algorithm
Screen
Diagnosis
Treatment
